Page last updated: 2024-08-05 11:04:51

1,1-bis(phosphonic acid)

Any member of the class of phosphonic acids in which a carbon atom is directly attached to two phosphonic acid groups. They are analogues of pyrophosphates (with the central oxygen atom replaced by a carbon atom) and like pyrophosphates they tend to have a strong affinity for bone, so are frequently used for their antiresorptive and hypocalcaemic properties.

ChEBI ID: 77383

Members (10)

MemberDefinitionRole
6-amino-1-hydroxyhexane-1,1-diphosphonateneridronic acid
alendronateA 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.alendronic acid
clodronic acidAn organochlorine compound that is methylene chloride in which both hydrogens are replaced by phosphonic acid groups. It inhibits bone resorption and soft tissue calcification, and is used (often as the disodium salt tetrahydrate) as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases.clodronic acid
etidronateA 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.etidronic acid
hydroxymethanediphosphonic acidoxidronic acid
incadronateincadronic acid
l 690330[1-(4-hydroxyphenoxy)-1-phosphonoethyl]phosphonic acid
methylene diphosphonateA 1,1-bis(phosphonic acid) consisting of methane substituted by two phosphonic acid groups.medronic acid
risedronate sodiumRisedronate sodium
zoledronic acidAn imidazole compound having a 2,2-bis(phosphono)-2-hydroxyethane-1-yl substituent at the 1-position.zoledronic acid

Research

Studies (11,201)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990815 (7.28)18.7374
1990's1,298 (11.59)18.2507
2000's3,655 (32.63)29.6817
2010's4,277 (38.18)24.3611
2020's1,156 (10.32)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials2,100 (16.19%)5.53%
Reviews1,585 (12.22%)6.00%
Case Studies1,322 (10.19%)4.05%
Observational76 (0.59%)0.25%
Other7,891 (60.82%)84.16%